Tamarind Bio
PrivateLast Round
Series A
Feb 26, 2026
Total Funding Raised
$27.2M
Momentum Score
25 /100
Company Overview
Tamarind Bio is a biotechnology company that develops a no-code computational platform for drug discovery. The company provides a website and an API that allow scientists to use bioinformatics tools for structural biology, including protein structure prediction, protein design, and molecular docking, without needing to manage complex computing infrastructure. Founded in 2023 by Stanford University graduates Deniz Kavi and Sherry Liu, the company aims to simplify and accelerate in silico experiments for researchers at pharmaceutical companies, biotechs, and academic institutions. Tamarind Bio is a graduate of the Y Combinator Winter 2024 batch and has raised $14.1 million in funding from investors including Y Combinator, 468 Capital, Phosphor Capital, and Treeo VC.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Vertical SaaS, Low-Code/No-Code, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting, Freemium
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tamarind Bio Comps
Public and private peers based on sector, stage, and business model.
Tamarind Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 26, 2026 | ||||
| Series A | May 15, 2025 |
Key People
Founding team and executive leadership
Tamarind Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dimension | Series A |
| Treeo VC | Series A |
| Phosphor Capital | Series A |
| Y Combinator | Series A |
| Dimension | Series A |
| 468 Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Streamlines experimental validation for AI-enabled antibody discovery.
- Mar 17, 2026
Added Flagship Pioneering Company as a customer.
Tamarind Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tamarind Bio's valuation, stock price, and market status.
